Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive and Cerebral Mechanisms of Anosognosia in Patients With Acquired Brain Damage: New Evaluation Strategies Based on Daily Tasks

NCT03712839 is registered in ClinicalTrials.gov with María Rodríguez Bailón as lead sponsor.

NCT NCT03712839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03712839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive and Cerebral Mechanisms of Anosognosia in Patients With Acquired Brain Damage: New Evaluation Strategies Based on Daily Tasks
Lead sponsor
María Rodríguez Bailón
Phase
Observational
Overall status
Completed
Start date
October 18, 2016
Completion date
June 30, 2022
Enrollment
48 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anosognosia, brain damage